Search

Experts

  • Dmitry Khalilov
    Dmitry Khalilov
    Partner, Tax & Law; Life Science: Biotechnology, Pharmaceutical, Medical Technology Leader, Russia and CIS, EY Moscow
  • Dmitry Khalilov
    Dmitry Khalilov
    Partner, Tax & Law; Life Science: Biotechnology, Pharmaceutical, Medical Technology Leader, Russia and CIS, EY Moscow

Dmitry Khalilov graduated from the Moscow Institute for Public and Corporate Management and from the Department of Civil Law, Moscow State Law Academy.

Dmitry Khalilov has been providing consulting services to the pharmaceutical enterprises and companies working in retail sector and goods production for over 15 years.

He has supervised projects on consulting the international and Russian companies on policy development and tax optimization within the framework of the international and Russian legislation, as well as tax assessment of international transactions on the domestic market.

He has also provided consulting advice on the organizational and financial structure of the enterprises and participated in various projects on initial public offering of the Russian companies planning to enter international capital markets.

He has worked with a number of companies including Takeda (Nycomed), Novo Nordisk, Abbott Laboratories, Astellas Pharma, AstraZeneca, Berlin-Chemie/Menarini, Teva, Johnson & Johnson, Pfizer, UCB, Merck, Farmstandart, Novartis, Cherkizovo Group, DIXY Group of Companies, Svyaznoi Group of Companies, Magnit Retail Chain.

At present: Partner, Tax & Law; Life Science: Biotechnology, Pharmaceutical, Medical Technology Leader, Russia and CIS, EY Moscow.